Cigna Group reported revenue of $71.67B for the period ended 2026-06-30, +6.7% year on year. Net income was $1.66B, a 2.3% net margin on a 20.9% gross margin. The largest revenue line is Evernorth at 80% of the total. Free cash flow for the period was $-0.72B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $71.67B | +6.7% |
| Gross profit | $14.96B | — |
| Operating income | $2.68B | — |
| Net income | $1.66B | +8.4% |
| Gross margin | 20.9% | Net margin 2.3% |
| Revenue Q/Q | +4.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| Evernorth | $57.49B | 80.2% |
| Service | $4.37B | 6.1% |
| Service Fees And Other Revenues | $4.37B | 6.1% |
| Service Other | $0.32B | 0.4% |
| All Other Segments | $0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $56.70B | 79.1% |
| SG&A | $3.47B | 4.8% |
| Tax & other | $1.02B | 1.4% |
| Item | Amount |
|---|---|
| Total assets | $157.08B |
| Total liabilities | $114.17B |
| Shareholders' equity | $42.91B |
| Equity / assets | 27.3% |
| Operating cash flow | $-0.42B |
| Capital expenditure | $0.30B |
| Free cash flow | $-0.72B |
| Cash conversion (OCF / net income) | -25% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CINF ・ CTAS ・ CSCO ・ C ・ CFG ・ CLX ・ CME ・ CMS ・ KO ・ CTSH ・ COHR ・ COIN
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies